India approves first dengue vaccine Qdenga for 4-60 age group
The story in brief
India has approved its first dengue vaccine, Qdenga, for individuals aged 4 to 60 years, based on evidence from a global clinical development programme. The vaccine, manufactured by Takeda Biopharmaceuticals India Pvt Ltd, is supplied as a freeze-dried powder and requires two doses administered three months apart. It has already received regulatory approval in 42 countries and has been distributed globally with over 24 million doses given out.